Pharma Stocks Rally as Budget Proposes Rs 10,000 Crore Boost for Biopharma Sector

Pharmaceutical sector stocks moved higher on Sunday after Finance Minister Nirmala Sitharaman announced a proposed investment of Rs 10,000 crore in the biopharma sector over the next five years, a step aimed at strengthening India’s pharmaceuticals ecosystem.

Pharma Stocks See Broad-Based Buying​

Following the announcement, several listed pharma and biotech companies recorded gains on the BSE. Shares of Anthem Biosciences jumped 6.49 percent, while Biocon rose 2.93 percent. Syngene International advanced 2.78 percent and Panacea Biotec climbed 2.56 percent.

Other stocks also traded higher, including Natco Pharma up 1.63 percent, Concord Biotech gaining 1.54 percent, Dr Reddy’s Laboratories rising 1.37 percent, and Gland Pharma adding 1.10 percent.

Broader Market Trades Higher​

The positive sentiment in pharma stocks came alongside gains in the broader market. The BSE Sensex was trading 281.75 points higher at 82,532.68, while the NSE Nifty edged up by 61.10 points to 25,376.05.

Focus on Biopharma and Advanced Sectors​

During the Budget presentation, the Finance Minister outlined the proposed Rs 10,000 crore investment for the biopharma sector, to be rolled out over a five-year period. Biopharmaceuticals, also known as biologics, are complex medicines derived from living organisms, cells, or tissues, rather than through chemical synthesis.

In addition to biopharma, the Budget proposals also highlighted planned interventions across six key areas, including manufacturing, strategic and frontier sectors, healthcare, and advanced technology, indicating a broader push toward strengthening high-value and innovation-driven industries.